Chromothripsis is linked to TP53 alteration, cell cycle impairment, and dismal outcome in acute myeloid leukemia with complex karyotype

Documenti analoghi

• getITD for FLT3-ITD-based MRD monitoring in AML
  di: Blätte, Tamara J., et al.
  Pubblicazione: (2019)
• Haploinsufficiency of ETV6 and CDKN1B in patients with acute myeloid leukemia and complex karyotype
  di: Feurstein, Simone, et al.
  Pubblicazione: (2014)
• Monosomal karyotype and chromosome 17p loss or TP53 mutations in decitabine-treated patients with acute myeloid leukemia
  di: Becker, Heiko, et al.
  Pubblicazione: (2020)
• Clonal evolution patterns in acute myeloid leukemia with NPM1 mutation
  di: Cocciardi, Sibylle, et al.
  Pubblicazione: (2019)
• MicroRNA expression-based outcome prediction in acute myeloid leukemia: novel insights through cross-platform integrative analyses
  di: Shivarov, Velizar, et al.
  Pubblicazione: (2016)